Here, we found that the DNA virus oncoproteins LMP1 and E7 inhibit PERK activity through a conserved DLLC domain, which on the one hand results in tumor progression driven by ROS signaling, but on the other hand, sensitize tumors to chemotherapy possibly via disturbed redox homeostasis. Here, PDLIM7 is linked to neoplasm.